GMiA Code of Practice

Members of GMiA adhere to a high standard of behaviour and are pleased to formalise this via the adoption of the first edition of their own Code of Practice introduced 1 March 2010.

The GMiA Code of Practice is principle based, providing guidance in a single document, on the different legislation, regulation and guidelines with which sponsors of generic medicines listed on the Australian Register of Therapeutic Goods (ARTG) comply.

The GMiA seeks to use all reasonable endeavours to provide healthcare professionals and consumers with a quick, effective and cost free method for redress of potential complaints against a member with regard to breaches of the Code.

Complaints from stakeholders should, in the first instance, be referred back to the respective member who will use all reasonable endeavours to resolve the complaint quickly and effectively. If the stakeholder is not satisfied with the action or decision of the member, the stakeholder may refer the complaint to the GMiA Code Complaint Committee via the GMiA secretariat at code@gmia.com.au.

For detailed information on the Code of Practice, please refer to the Code document on this website

GMiA welcomes and encourages feedback from stakeholders. Feedback can be submitted to code@gmia.com.au.

Click here to view GMiA Code of Practice

Members of GMiA are currently seeking authorisation by the Australian Competition and Consumer Commission (ACCC) of the second edition of the GMiA Code of Practice.

Members of GMiA will continue to adhere to the current (first) edition of the GMiA Code of Practice during the six month ACCC authorisation review period.

GMiA welcomes and encourages feedback from stakeholders. Feedback can be submitted to code@gmia.com.au.

Click here to view draft second edition GMiA Code of Practice

Developed by The Pagesmith